Dr. John Kellie
Bioanalysis, Immunogenicity & Biomarkers, GSKDr. John Kellie on Developing a Whole Molecule Approach for Biopharmaceutical Analysis
1 Aug 2016
Dr. John Kellie, Associate Fellow, Bioanalysis, Immunogenicity and Biomarkers, GSK, describes a technique for the quantitation of whole molecule biopharmaceutical candidates using high-resolution mass spec.
LIKE
0
Related Scientists
-
Health SciencesJudy Stone, MT(ASCP), Ph.D., DABCC University of California San Diego Health Center for Advanced Laboratory Medicine -
Health SciencesProfessor Coral Barbas Director of the Center for Metabolomics and Bioanalysis, Universidad CEU-San Pablo, Madrid, Spain -
-
Mass SpectrometryJennifer Van Eyk, PhD Director, Advanced Clinical Biosystems Institute in the Department of Biomedical Sciences
-
-
-
Mass SpectrometryProfessor Philip Britz-McKibbin McMaster University, Department of Chemistry & Chemical Biology -
Health SciencesProfessor Stephen Pennington Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland
-
-
Health SciencesDr. Ganesh Anand Associate Professor, Department of Biological Sciences, National University of Singapore -
Health SciencesDr. Robert Trengove Separation Science and Metabolomics Laboratory, Murdoch University, Australia -
-
-
Health SciencesProfessor Vicki Wysocki Chemistry and Biochemistry Department, The Ohio State University -
Related Content
Health Sciences
Mass Spectrometry